Minimally invasive strategies for left ventricular assist device implantation

被引:1
作者
Weymann A. [1 ,2 ]
Schmack B. [1 ,2 ]
Sabashnikov A. [2 ,3 ]
Zeriouh M. [2 ,3 ]
Ruhparwar A. [1 ]
Simon A.R. [2 ]
Popov A.-F. [2 ]
机构
[1] Klinik für Herzchirurgie, Herz- und Marfanzentrum, Universität Heidelberg, Im Neuenheimer Feld 110, Heidelberg
[2] Department of Cardiothoracic Transplantation & Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, Hill End Road, London, Harefield, Middlesex
[3] Klinik für Herz- und Thoraxchirurgie, Herzzentrum – Universität Köln, Kerpener Straße 61, Köln
关键词
End-stage heart failure; Heart assist devices; Mechanical circulatory support; Minimally invasive surgery; Patient selection;
D O I
10.1007/s00398-016-0063-8
中图分类号
学科分类号
摘要
Heart transplantation remains the gold standard for patients with end-stage heart failure. Due to the lack of donor organs the increasing use of left ventricular assist devices (LVAD) has gained a paramount role in heart failure surgery. The conventional technique of LVAD implantation involves median sternotomy and connection to a heart-lung machine. More recent approaches show the progressive development of alternative and less invasive implantation techniques, not least because of the radical downsizing of the pump housing of current generation LVAD systems. As a result of the intrapericardial position of LVADs numerous minimally invasive strategies have already been developed. Moreover, the off-pump implantation technique is increasingly being used in some centers. In this study we present the new developments in the field of minimally invasive LVAD surgery and give an insight into the practical approach. Particular attention is given to appropriate patient selection and critical discussion on the possible advantages and disadvantages of each technique. © 2016, Springer-Verlag Berlin Heidelberg.
引用
收藏
页码:90 / 96
页数:6
相关论文
共 22 条
[1]  
Slaughter M.S., Rogers J.G., Milano C.A., Et al., Advanced heart failure treated with continuous-flow left ventricular assist device, N Engl J Med, 361, pp. 2241-2251, (2009)
[2]  
Popov A.F., Hosseini M.T., Zych B., Simon A.R., Bahrami T., HeartWare left ventricular assist device implantation through bilateral anterior thoracotomy, Ann Thorac Surg, 93, 2, pp. 674-676, (2012)
[3]  
Schmitto J.D., Molitoris U., Haverich A., Et al., Implantation of a centrifugal pump as a left ventricular assist device through a novel, minimized approach: upper hemisternotomy combined with anterolateral thoracotomy, J Thorac Cardiovasc Surg, 143, pp. 511-513, (2012)
[4]  
Garcia S.D., Mohite P.N., Zych B., Et al., Minimally invasive access for off-pump HeartWare left ventricular assist device explantation, Interact Cardiovasc Thorac Surg, 17, pp. 581-582, (2013)
[5]  
Sabashnikov A., Mohite P.N., Simon A.R., Popov A.F., HeartWare miniaturized intrapericardial ventricular assist device: advantages and adverse events in comparison to contemporary devices, Expert Rev Med Devices, 10, 4, pp. 441-452, (2013)
[6]  
Schmitto J.D., Hanke J.S., Rojas S.V., Avsar M., Haverich A., First implantation in man of a new magnetically levitated left ventricular assist device (HeartMateIII), J Heart Lung Transplant, 34, 6, pp. 858-860, (2015)
[7]  
McGee E., Chorpenning K., Brown M.C., Breznock E., Larose J.A., Tamez D., In vivo evaluation of the HeartWare MVAD Pump, J Heart Lung Transplant, 33, 4, pp. 366-371, (2014)
[8]  
Tamez D., LaRose J.A., Shambaugh C., Chorpenning K., Soucy K.G., Sobieski M.A., Sherwood L., Giridharan G.A., Monreal G., Koenig S.C., Slaughter M.S., Early feasibility testing and engineering development of the transapical approach for the HeartWare MVAD ventricular assist system, ASAIO J, 60, 2, pp. 170-177, (2014)
[9]  
Topilsky Y., Hasin T., Oh J.K., Et al., Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome, Circ Cardiovasc Imaging, 4, pp. 648-661, (2011)
[10]  
Dell'Italia L.J., Anatomy and physiology of the right ventricle, Cardiol Clin, 30, pp. 167-187, (2012)